Plasmonic two-nanopore technology for single-molecule protein sequencing (Acronym: TwoPoreProSeq)
Description of the granted funding
While portable single-molecule DNA sequencers have been brought to African and Brazil villages for sequencing Ebola and Zika virus, no corresponding technologies exist for protein sequencing. The big gap hampers not only mechanistic studies but also clinical applications. The latter includes digital health and personalized medicine that aims to provide customized treatment to individual patients based on dynamic personal health data collected by Point-of-care diagnostic devices. The TwoPoreProSeq project aims to develop a novel plasmonic two-nanopore device able to unfold and sequence single protein molecules by plasmon-enhanced Raman spectroscopy. It can provide a single-molecule protein sequencing technology to Point-of-Care devices, allowing peoples in both developed and underdeveloped countries to acquire data of their health and diseases at home for health management.
Show moreStarting year
2022
End year
2027
Granted funding
Related funding decisions
368482
Research costs of Academy Research Fellows(2025)
159 771 €
353776
Research costs of Academy Research Fellows(2022)
240 000 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Decision maker
Scientific Council for Natural Sciences and Engineering
12.05.2022
12.05.2022
Other information
Funding decision number
347652
Fields of science
Nanotechnology
Research fields
Nanotiede ja -tekniikka
Identified topics
genes, genetics